DOI QR코드

DOI QR Code

Endoscopic Imaging in Barrett's Oesophagus: Applications in Routine Clinical Practice and Future Outlook

  • Published : 2011.12.30

Abstract

The practice for endoscopic surveillance of Barrett's oesophagus has evolved from "blind" or random 4 quadrant biopsies (Seattle protocol) to a more "intelligent'' targeted biopsy approach. This evolution has been possible due to the rapid advances in endoscopic imaging technology and expertise in the last decade. Previous endoscopes had relatively poor image resolution that often did not allow the subtle mucosal changes associated with dysplastic Barrett's mucosa to be identified. Newer endoscopic imaging techniques available today may allow endoscopists to identify areas of dysplasia or malignancy and target biopsies accordingly. These modalities which include narrow band imaging, chromoendoscopy, autofluorescence imaging, and confocal endomicroscopy as well as a few novel imaging modalities on the horizon will be discussed further.

Keywords

References

  1. Dent J. Barrett's esophagus: a historical perspective, an update on core practicalities and predictions on future evolutions of management. J Gastroenterol Hepatol 2011;26 Suppl 1:11-30. https://doi.org/10.1111/j.1440-1746.2010.06535.x
  2. Portale G, Hagen JA, Peters JH, et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 2006;202:588-596. https://doi.org/10.1016/j.jamcollsurg.2005.12.022
  3. Mandal A, Playford RJ, Wicks AC. Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK. Aliment Pharmacol Ther 2003;17:1319-1324. https://doi.org/10.1046/j.1365-2036.2003.01586.x
  4. Abrams JA, Kapel RC, Lindberg GM, et al. Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol 2009;7:736-742. https://doi.org/10.1016/j.cgh.2008.12.027
  5. Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006;131:1392-1399. https://doi.org/10.1053/j.gastro.2006.08.032
  6. Chang CY, Lee YC, Lee CT, et al. The application of Prague C and M criteria in the diagnosis of Barrett's esophagus in an ethnic Chinese population. Am J Gastroenterol 2009;104:13-20. https://doi.org/10.1038/ajg.2008.43
  7. Lee YC, Cook MB, Bhatia S, et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett's esophagus: an Asian multinational study. Endoscopy 2010;42:699-704. https://doi.org/10.1055/s-0030-1255629
  8. Kara MA, Peters FP, Rosmolen WD, et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study. Endoscopy 2005;37:929-936. https://doi.org/10.1055/s-2005-870433
  9. Wolfsen HC, Crook JE, Krishna M, et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus. Gastroenterology 2008;135:24-31. https://doi.org/10.1053/j.gastro.2008.03.019
  10. Sharma P, Meining A, Coron E, et al. Detection of neoplastic tissue in Barrett's esophagus with in vivo probe-based confocal endomicroscopy (DONT BIOPCE). Final results of a prospective international RCT: image guided versus 4 quadrant random biopsies? Gastroenterology 2010; 138(5 Suppl 1):S-155.
  11. Singh R, Karageorgiou H, Owen V, et al. Comparison of high-resolution magnification narrow-band imaging and white-light endoscopy in the prediction of histology in Barrett's oesophagus. Scand J Gastroenterol 2009;44:85-92. https://doi.org/10.1080/00365520802400818
  12. Fortun PJ, Anagnostopoulos GK, Kaye P, et al. Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus. Aliment Pharmacol Ther 2006;23:735-742. https://doi.org/10.1111/j.1365-2036.2006.02823.x
  13. Longcroft-Wheaton G, Duku M, Mead R, Poller D, Bhandari P. Acetic acid spray is an effective tool for the endoscopic detection of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2010;8: 843-847. https://doi.org/10.1016/j.cgh.2010.06.016
  14. Canto MI, Setrakian S, Willis JE, Chak A, Petras RE, Sivak MV. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study. Endoscopy 2001;33:391-400. https://doi.org/10.1055/s-2001-14427
  15. Ngamruengphong S, Sharma VK, Das A. Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis. Gastrointest Endosc 2009;69:1021-1028. https://doi.org/10.1016/j.gie.2008.06.056
  16. Wild CP, Sturmey RG, Olliver JR, Sahay P, Hardie LJ. Methylene blue, chromoendoscopy and DNA damage in human esophageal cells. Proc Am Assoc Cancer Res 2005;46:517-518.
  17. Sharma P, Weston AP, Topalovski M, Cherian R, Bhattacharyya A, Sampliner RE. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut 2003;52:24-27. https://doi.org/10.1136/gut.52.1.24
  18. Curvers WL, Singh R, Wallace MB, et al. Identification of predictive factors for early neoplasia in Barrett's esophagus after autofluorescence imaging: a stepwise multicenter structured assessment. Gastrointest Endosc 2009;70:9-17. https://doi.org/10.1016/j.gie.2008.10.026
  19. Niepsuj K, Niepsuj G, Cebula W, et al. Autofluorescence endoscopy for detection of high-grade dysplasia in short-segment Barrett's esophagus. Gastrointest Endosc 2003;58:715-719. https://doi.org/10.1016/S0016-5107(03)02018-2
  20. Thomas T, Singh R, Ragunath K. Trimodal imaging-assisted endoscopic mucosal resection of early Barrett's neoplasia. Surg Endosc 2009;23: 1609-1613. https://doi.org/10.1007/s00464-009-0429-z
  21. Borovicka J, Fischer J, Neuweiler J, et al. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy. Endoscopy 2006;38:867-872. https://doi.org/10.1055/s-2006-944726
  22. Curvers WL, Herrero LA, Wallace MB, et al. Endoscopic tri-modal imaging is more effective than standard endoscopy in identifying early-stage neoplasia in Barrett's esophagus. Gastroenterology 2010;139:1106-1114. https://doi.org/10.1053/j.gastro.2010.06.045
  23. Kara MA, Smits ME, Rosmolen WD, et al. A randomized crossover study comparing light-induced fluorescence endoscopy with standard videoendoscopy for the detection of early neoplasia in Barrett's esophagus. Gastrointest Endosc 2005;61:671-678. https://doi.org/10.1016/S0016-5107(04)02777-4
  24. Curvers WL, Singh R, Song LM, et al. Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system. Gut 2008;57:167-172. https://doi.org/10.1136/gut.2007.134213
  25. Curvers WL, van Vilsteren FG, Baak LC, et al. Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett's neoplasia: a multicenter, randomized, crossover study in general practice. Gastrointest Endosc 2011;73:195-203. https://doi.org/10.1016/j.gie.2010.10.014
  26. Canto MI. Endomicroscopy of Barrett's esophagus. Gastroenterol Clin North Am 2010;39:759-769. https://doi.org/10.1016/j.gtc.2010.08.032
  27. Wallace MB, Meining A, Canto MI, et al. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther 2010;31:548-552. https://doi.org/10.1111/j.1365-2036.2009.04207.x
  28. Neumann H, Kiesslich R, Wallace MB, Neurath MF. Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterology 2010;139:388-392. https://doi.org/10.1053/j.gastro.2010.06.029
  29. Kiesslich R, Gossner L, Goetz M, et al. In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol 2006;4:979-987. https://doi.org/10.1016/j.cgh.2006.05.010
  30. Dunbar KB, Okolo P 3rd, Montgomery E, Canto MI. Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial. Gastrointest Endosc 2009;70:645-654. https://doi.org/10.1016/j.gie.2009.02.009
  31. Leung KK, Maru D, Abraham S, Hofstetter WL, Mehran R, Anandasabapathy S. Optical EMR: confocal endomicroscopy-targeted EMR of focal high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 2009;69:170-172. https://doi.org/10.1016/j.gie.2008.03.1068
  32. Pohl H, Rosch T, Vieth M, et al. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut 2008;57:1648-1653. https://doi.org/10.1136/gut.2008.157461
  33. Bajbouj M, Vieth M, Rosch T, et al. Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus. Endoscopy 2010;42:435-440. https://doi.org/10.1055/s-0029-1244194
  34. Cengia G, Missale G, Minelli L, Villanacci V, Rossi E, Cestari R. Screening for and surveillance of Barrett's esophagus is clinically indicated. Dig Dis 2007;25:197-202. https://doi.org/10.1159/000103884
  35. Jin Z, Cheng Y, Gu W, et al. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res 2009;69:4112-4115.
  36. Rabinovitch PS, Longton G, Blount PL, Levine DS, Reid BJ. Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol 2001;96:3071-3083. https://doi.org/10.1111/j.1572-0241.2001.05261.x
  37. Zagaynova E, Gladkova N, Shakhova N, Gelikonov G, Gelikonov V. Endoscopic OCT with forward-looking probe: clinical studies in urology and gastroenterology. J Biophotonics 2008;1:114-128. https://doi.org/10.1002/jbio.200710017
  38. Waxman I, Konda VJ. Endoscopic techniques for recognizing neoplasia in Barrett's esophagus: which should the clinician use? Curr Opin Gastroenterol 2010;26:352-360. https://doi.org/10.1097/MOG.0b013e32833ad5c4
  39. Georgakoudi I, Jacobson BC, Van Dam J, et al. Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. Gastroenterology 2001;120:1620-1629. https://doi.org/10.1053/gast.2001.24842
  40. El-Serag HB, Naik AD. Surveillance in Barrett's esophagus: lessons from behavioral economics. Gastroenterology 2009;137:763-765. https://doi.org/10.1053/j.gastro.2009.07.031

Cited by

  1. Preliminary feasibility study using a novel narrow‐band imaging system with dual focus magnification capability in Barrett's esophagus: Is the time ripe to abandon random biopsies? vol.25, pp.2, 2013, https://doi.org/10.1111/den.12106